The Antioxidant Therapy: New Insights in the Treatment of Hypertension.

Authors:
Daniela Sorriento
Daniela Sorriento
Department of Clinical Medicine
Italy
Bruno Trimarco
Bruno Trimarco
Federico II University
Napoli | Italy
Prof. Guido Iaccarino, MD, PhD
Prof. Guido Iaccarino, MD, PhD
Federico II University of Naples
Full Professor of Applied Medical Science and Technology
Cardiology
Napoli, Campania | Italy

Front Physiol 2018 21;9:258. Epub 2018 Mar 21.

Dipartimento di Medicina, Chirurgia e Odontoiatria, Università degli Studi di Salerno, Baronissi, Italy.

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a key role in the regulation of the physiological and pathological signaling within the vasculature. In physiological conditions, a delicate balance between oxidants and antioxidants protects cells from the detrimental effects of ROS/RNS. Indeed, the imbalance between ROS/RNS production and antioxidant defense mechanisms leads to oxidative and nitrosative stress within the cell. These processes promote the vascular damage observed in chronic conditions, such as hypertension. The strong implication of ROS/RNS in the etiology of hypertension suggest that antioxidants could be effective in the treatment of this pathology. Indeed, in animal models of hypertension, the overexpression of antioxidants and the genetic modulation of oxidant systems have provided an encouraging proof of concept. Nevertheless, the translation of these strategies to human disease did not reach the expected success. This could be due to the complexity of this condition, whose etiology depends on multiple factors (smoking, diet, life styles, genetics, family history, comorbidities). Indeed, 95% of reported high blood pressure cases are deemed "essential hypertension," and at the molecular level, oxidative stress seems to be a common feature of hypertensive states. In this scenario, new therapies are emerging that could be useful to reduce oxidative stress in hypertension. It is now ascertained the role of Vitamin D deficiency in the development of essential hypertension and it has been shown that an appropriate high dose of Vitamin D significantly reduces blood pressure in hypertensive cohorts with vitamin D deficiency. Moreover, new drugs are emerging which have both antihypertensive action and antioxidant properties, such as celiprolol, carvedilol, nebivolol. Indeed, besides adrenergic desensitization, these kind of drugs are able to interfere with ROS/RNS generation and/or signaling, and are therefore considered promising therapeutics in the management of hypertension. In the present review we have dealt with the effectiveness of the antioxidant therapy in the management of hypertension. In particular, we discuss about Vitamin D and anti-hypertensive drugs with antioxidant properties.

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphys.2018.00258DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871811PMC

Still can't find the full text of the article?

We can help you send a request to the authors directly.
March 2018

Article Mentions


Provided by Crossref Event Data
twitter
Twitter: FrontPhysiol
March 27, 2018, 6:13 pm EST
twitter
Twitter: Guiaccar
March 21, 2018, 2:16 pm EST

Publication Analysis

Top Keywords

hypertension
8
oxidative stress
8
antioxidant properties
8
blood pressure
8
management hypertension
8
vitamin deficiency
8
antioxidant therapy
8
antioxidant
5
strategies human
4
action antioxidant
4
etiology depends
4
translation strategies
4
concept translation
4
properties celiprolol
4
proof concept
4
human disease
4
deficiency drugs
4
antihypertensive action
4
success complexity
4
complexity condition
4

References

(Supplied by CrossRef)
Antioxidant supplementation in hypertension
Ardalan et al.
J. Renal Inj. Prev. 2014
Oxidative stress and hypertension: possibility of hypertension therapy with antioxidants
Baradaran et al.
J. Res. Med. Sci. 2014

Similar Publications